A citation-based method for searching scientific literature

Janine M Simons, Thiemo J A van Nijnatten, Carmen C van der Pol, Ernest J T Luiten, Linetta B Koppert, Marjolein L Smidt. Ann Surg 2019
Times Cited: 47







List of co-cited articles
259 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
Judy C Boughey, Vera J Suman, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, A Marilyn Leitch, Henry M Kuerer, Monet Bowling, Teresa S Flippo-Morton,[...]. JAMA 2013
655
59

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
Abigail S Caudle, Wei T Yang, Savitri Krishnamurthy, Elizabeth A Mittendorf, Dalliah M Black, Michael Z Gilcrease, Isabelle Bedrosian, Brian P Hobbs, Sarah M DeSnyder, Rosa F Hwang,[...]. J Clin Oncol 2016
329
59

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Thorsten Kuehn, Ingo Bauerfeind, Tanja Fehm, Barbara Fleige, Maik Hausschild, Gisela Helms, Annette Lebeau, Cornelia Liedtke, Gunter von Minckwitz, Valentina Nekljudova,[...]. Lancet Oncol 2013
601
51

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.
Jean-Francois Boileau, Brigitte Poirier, Mark Basik, Claire M B Holloway, Louis Gaboury, Lucas Sideris, Sarkis Meterissian, Angel Arnaout, Muriel Brackstone, David R McCready,[...]. J Clin Oncol 2015
329
46

Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.
Mila Donker, Marieke E Straver, Jelle Wesseling, Claudette E Loo, Margaret Schot, Caroline A Drukker, Harm van Tinteren, Gabe S Sonke, Emiel J Th Rutgers, Marie-Jeanne T F D Vrancken Peeters. Ann Surg 2015
185
40

A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study.
Thiemo J A van Nijnatten, Janine M Simons, Marjolein L Smidt, Carmen C van der Pol, Paul J van Diest, Agnes Jager, David van Klaveren, Boen L R Kam, Marc B I Lobbes, Maaike de Boer,[...]. Clin Breast Cancer 2017
48
38

Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).
Judy C Boughey, Karla V Ballman, Huong T Le-Petross, Linda M McCall, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, Eric C Feliberti, Kelly K Hunt. Ann Surg 2016
202
29

Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.
Christian Siso, Juan de Torres, Antonio Esgueva-Colmenarejo, Martin Espinosa-Bravo, Neus Rus, Octavi Cordoba, Roberto Rodriguez, Vicente Peg, Isabel T Rubio. Ann Surg Oncol 2018
52
27

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
Jean-Marc Classe, Cecile Loaec, P Gimbergues, S Alran, C Tunon de Lara, P F Dupre, Roman Rouzier, C Faure, N Paillocher, M P Chauvet,[...]. Breast Cancer Res Treat 2019
52
27

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Mila Donker, Geertjan van Tienhoven, Marieke E Straver, Philip Meijnen, Cornelis J H van de Velde, Robert E Mansel, Luigi Cataliotti, A Helen Westenberg, Jean H G Klinkenbijl, Lorenzo Orzalesi,[...]. Lancet Oncol 2014
762
25

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Armando E Giuliano, Karla V Ballman, Linda McCall, Peter D Beitsch, Meghan B Brennan, Pond R Kelemen, David W Ollila, Nora M Hansen, Pat W Whitworth, Peter W Blumencranz,[...]. JAMA 2017
481
25

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Norikazu Masuda, Soo-Jung Lee, Shoichiro Ohtani, Young-Hyuck Im, Eun-Sook Lee, Isao Yokota, Katsumasa Kuroi, Seock-Ah Im, Byeong-Woo Park, Sung-Bae Kim,[...]. N Engl J Med 2017
495
23

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
Gunter von Minckwitz, Chiun-Sheng Huang, Max S Mano, Sibylle Loibl, Eleftherios P Mamounas, Michael Untch, Norman Wolmark, Priya Rastogi, Andreas Schneeweiss, Andres Redondo,[...]. N Engl J Med 2019
625
23

Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy.
Steffi Hartmann, Toralf Reimer, Bernd Gerber, Johannes Stubert, Bernd Stengel, Angrit Stachs. Eur J Surg Oncol 2018
41
26

Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.
Judy C Boughey, Linda M McCall, Karla V Ballman, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, A Marilyn Leitch, Teresa Flippo-Morton, Kelly K Hunt. Ann Surg 2014
204
23

Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
Emilia J Diego, Priscilla F McAuliffe, Atilla Soran, Kandace P McGuire, Ronald R Johnson, Marguerite Bonaventura, Gretchen M Ahrendt. Ann Surg Oncol 2016
75
23

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014
21

Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment.
V Galimberti, S K Ribeiro Fontana, P Maisonneuve, F Steccanella, A R Vento, M Intra, P Naninato, P Caldarella, M Iorfida, M Colleoni,[...]. Eur J Surg Oncol 2016
77
19

Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients.
Seho Park, Ja Seung Koo, Gun Min Kim, Joohyuk Sohn, Seung Il Kim, Young Up Cho, Byeong-Woo Park, Vivian Youngjean Park, Jung Hyun Yoon, Hee Jung Moon,[...]. Cancer Res Treat 2018
33
27

Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.
Laura S Dominici, Viviana M Negron Gonzalez, Aman U Buzdar, Anthony Lucci, Elizabeth A Mittendorf, Huong T Le-Petross, Gildy V Babiera, Funda Meric-Bernstam, Kelly K Hunt, Henry M Kuerer. Cancer 2010
131
19

Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients.
Nicole Choy, Jafi Lipson, Catherine Porter, Michael Ozawa, Anne Kieryn, Sunita Pal, Jennifer Kao, Long Trinh, Amanda Wheeler, Debra Ikeda,[...]. Ann Surg Oncol 2015
61
17


Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer.
S R Tee, L A Devane, D Evoy, J Rothwell, J Geraghty, R S Prichard, E W McDermott. Br J Surg 2018
44
18

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Viviana Galimberti, Bernard F Cole, Giuseppe Viale, Paolo Veronesi, Elisa Vicini, Mattia Intra, Giovanni Mazzarol, Samuele Massarut, Janez Zgajnar, Mario Taffurelli,[...]. Lancet Oncol 2018
155
17


Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery.
Audree B Tadros, Wei T Yang, Savitri Krishnamurthy, Gaiane M Rauch, Benjamin D Smith, Vicente Valero, Dalliah M Black, Anthony Lucci, Abigail S Caudle, Sarah M DeSnyder,[...]. JAMA Surg 2017
84
17

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
Eleftherios P Mamounas, Ann Brown, Stewart Anderson, Roy Smith, Thomas Julian, Barbara Miller, Harry D Bear, Christopher B Caldwell, Alonzo P Walker, Wendy M Mikkelson,[...]. J Clin Oncol 2005
323
14

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
David N Krag, Stewart J Anderson, Thomas B Julian, Ann M Brown, Seth P Harlow, Joseph P Costantino, Takamaru Ashikaga, Donald L Weaver, Eleftherios P Mamounas, Lynne M Jalovec,[...]. Lancet Oncol 2010
917
14

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
Gunter von Minckwitz, Michael Untch, Jens-Uwe Blohmer, Serban D Costa, Holger Eidtmann, Peter A Fasching, Bernd Gerber, Wolfgang Eiermann, Jörn Hilfrich, Jens Huober,[...]. J Clin Oncol 2012
14

Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
Tracy-Ann Moo, Marcia Edelweiss, Sabina Hajiyeva, Michelle Stempel, Monica Raiss, Emily C Zabor, Andrea Barrio, Monica Morrow. Ann Surg Oncol 2018
43
16

Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment.
Ioannis Natsiopoulos, Stavros Intzes, Triantafyllos Liappis, Konstantinos Zarampoukas, Thomas Zarampoukas, Vasiliki Zacharopoulou, Konstantinos Papazisis. Clin Breast Cancer 2019
16
43

Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
Neslihan Cabıoğlu, Hasan Karanlık, Dilek Kangal, Enver Özkurt, Gizem Öner, Fatma Sezen, Ravza Yılmaz, Mustafa Tükenmez, Semen Önder, Abdullah İğci,[...]. Ann Surg Oncol 2018
19
36

Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.
M E M van der Noordaa, F H van Duijnhoven, M E Straver, E J Groen, M Stokkel, C E Loo, P H M Elkhuizen, N S Russell, M T F D Vrancken Peeters. Ann Surg Oncol 2018
27
25


Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Viviana Galimberti, Bernard F Cole, Stefano Zurrida, Giuseppe Viale, Alberto Luini, Paolo Veronesi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Mattia Intra,[...]. Lancet Oncol 2013
665
14

Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.
Stephanie M Wong, Nora Almana, Jungeun Choi, Jiani Hu, Haley Gagnon, Kelsey Natsuhara, Abra H Shen, Stephen DeSantis, Laura Dominici, Mehra Golshan,[...]. Ann Surg Oncol 2019
20
35

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
Priya Rastogi, Stewart J Anderson, Harry D Bear, Charles E Geyer, Morton S Kahlenberg, André Robidoux, Richard G Margolese, James L Hoehn, Victor G Vogel, Shaker R Dakhil,[...]. J Clin Oncol 2008
12

Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
Edwin R Fisher, Jiping Wang, John Bryant, Bernard Fisher, Eletherios Mamounas, Norman Wolmark. Cancer 2002
271
12

Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Toan T Nguyen, Tanya L Hoskin, Courtney N Day, Amy C Degnim, James W Jakub, Tina J Hieken, Judy C Boughey. Ann Surg Oncol 2018
33
18

Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial.
Abigail S Caudle, Wei T Yang, Elizabeth A Mittendorf, Daliah M Black, Rosa Hwang, Brian Hobbs, Kelly K Hunt, Savitri Krishnamurthy, Henry M Kuerer. JAMA Surg 2015
90
12

Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients.
Kelly K Hunt, Min Yi, Elizabeth A Mittendorf, Cynthia Guerrero, Gildy V Babiera, Isabelle Bedrosian, Rosa F Hwang, Henry M Kuerer, Merrick I Ross, Funda Meric-Bernstam. Ann Surg 2009
172
12

Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy.
Sarah S Mougalian, Mike Hernandez, Xiudong Lei, Siobhan Lynch, Henry M Kuerer, William F Symmans, Richard L Theriault, Bruno D Fornage, Limin Hsu, Thomas A Buchholz,[...]. JAMA Oncol 2016
69
12

The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB).
Oluwadamilola M Fayanju, Yi Ren, Samantha M Thomas, Rachel A Greenup, Jennifer K Plichta, Laura H Rosenberger, Nina Tamirisa, Jeremy Force, Judy C Boughey, Terry Hyslop,[...]. Ann Surg 2018
60
12

A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-Positive Breast Cancer Patients.
Sherko Kuemmel, Joerg Heil, Anna Rueland, Christine Seiberling, Hakima Harrach, Dorothea Schindowski, Juliane Lubitz, Karin Hellerhoff, Christine Ankel, Sven-Thomas Graßhoff,[...]. Ann Surg 2020
18
33

Axillary Nodal Management Following Neoadjuvant Chemotherapy: A Review.
Melissa Pilewskie, Monica Morrow. JAMA Oncol 2017
85
10

Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).
Judy C Boughey, Karla V Ballman, Kelly K Hunt, Linda M McCall, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Huong T Le-Petross. J Clin Oncol 2015
121
10

Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy.
B B Koolen, M Donker, M E Straver, M E M van der Noordaa, E J T Rutgers, R A Valdés Olmos, M J T F D Vrancken Peeters. Br J Surg 2017
25
20

Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases.
T J A van Nijnatten, J M Simons, M Moossdorff, L de Munck, M B I Lobbes, C C van der Pol, L B Koppert, E J T Luiten, M L Smidt. Breast Cancer Res Treat 2017
24
20


Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
Katsutoshi Enokido, Chie Watanabe, Seigo Nakamura, Akiko Ogiya, Tomo Osako, Futoshi Akiyama, Akiyo Yoshimura, Hiroji Iwata, Shinji Ohno, Yasuyuki Kojima,[...]. Clin Breast Cancer 2016
32
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.